Richard J Rodgers's Net Worth

$2.26 Million

Estimate Recalculated Nov 11, 2024 08:01AM EST

Who is Richard J Rodgers?

Richard J Rodgers has an estimated net worth of $2.26 Million. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Abraxis BioScience, Inc., TESARO, Inc., ARDELYX, INC., Ocuphire Pharma, Inc., NOVAVAX INC, and MGI PHARMA INC.

SEC CIK

Richard J Rodgers's CIK is 0001313397

Past Insider Trading and Trends

2023 was Richard J Rodgers's most active year for acquiring shares with 11 total transactions. Richard J Rodgers's most active month to acquire stocks was the month of May. 2008 was Richard J Rodgers's most active year for disposing of shares, totalling 10 transactions. Richard J Rodgers's most active month to dispose stocks was the month of December. 2007 saw Richard J Rodgers paying a total of $515,625.00 for 22,500 shares, this is the most they've acquired in one year. In 2008 Richard J Rodgers cashed out on 96,161 shares for a total of $1,912,056.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sagimet Biosciences Inc. (SGMT) Snapshot price: $2.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 18
Form 3
—
0
—
—
0
No matching records found

Abraxis BioScience, Inc. No price found

Senior Vice President and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
15K
—
—
15K
Jul 13
Form 3
—
0
—
—
0
No matching records found

TESARO, Inc. No price found

Executive VP & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 6
Form 4
+38.46%
71.43K
—
—
257.14K
Jul 3
Form 3
—
0
—
—
0
No matching records found

ARDELYX, INC. (ARDX) Snapshot price: $5.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.12%
12.2K
—
—
250.52K
Jun 14
Form 4
+8.41%
18.49K
—
—
238.32K
Jun 15
Form 4
+151.15%
132.3K
—
—
219.83K
Jun 15
Form 4
+12.78%
9.92K
—
—
87.53K
Jun 16
Form 4
+13.50%
9.23K
—
—
77.61K
Jun 9
Form 4
+56.32%
24.64K
—
—
68.38K
Jun 13
Form 4
+62.05%
16.75K
—
—
43.74K
Jun 13
Form 4
+138.96%
15.7K
—
—
26.99K
Jun 7
Form 4
+148.05%
6.74K
—
—
11.3K
Jun 2
Form 4
∞
4.55K
—
—
4.55K
Jun 11
Form 4
—
0
—
—
0
Jun 18
Form 3
—
0
—
—
0
No matching records found

Ocuphire Pharma, Inc. (OCUP) Snapshot price: $1.2001

Interim CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.78%
41.14K
—
—
239.15K
Jun 11
Form 4
+14.29%
24.76K
—
—
198.01K
Jan 1
Form 4
+25.32%
35K
—
—
173.25K
Nov 1
Form 4
+56.66%
50K
—
—
138.25K
Apr 19
Form 4
+30.88%
20.82K
—
—
88.25K
Jan 11
Form 4
+4.90%
3.15K
—
$0.31
67.42K
Oct 3
Form 4
+58.23%
23.65K
—
—
64.28K
Jul 1
Form 4
—
0
—
—
0
Jun 13
Form 4
+12.86%
4.63K
—
—
40.62K
Apr 1
Form 4
+12.58%
4.02K
—
—
35.99K
Jan 3
Form 4
+10.02%
2.91K
—
—
31.97K
Oct 1
Form 4
+10.83%
2.84K
—
—
29.06K
Jul 1
Form 4
—
0
—
—
0
Jun 7
Form 4
+10.92%
2.58K
—
—
26.22K
Apr 1
Form 4
+300.00%
17.73K
—
—
23.64K
Nov 19
Form 4
—
0
—
—
0
Nov 11
Form 4
∞
5.91K
—
—
5.91K
Nov 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Apr 11
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Sep 16
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found